Yu Chang
Impact in
-
- Lymphoma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
-
- Lymphoma Diagnosis and Treatment 29
- Oncology 28
- Viral-associated cancers and disorders 12
- Cancer-related Molecular Pathways 6
- Co-authors
- Ping’an Ma (7 shared papers)JM Lin (7 shared papers)Ziyong Cheng (3 shared papers)Xinyang Zhang (4 shared papers)Haihua Xiao (2 shared papers)Zhaoming Li (32 shared papers)Jianhua Liu (1 shared paper)Chunxia Li (1 shared paper)
- Journals
- Scientific Reports (4 papers)Cancer Management and Research (3 papers)Annals of Hematology (3 papers)Oncology Reports (2 papers)Cellular Physiology and Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu Chang
89 papers receiving 2.8k citations
Yu Chang's Hit Papers
Peers
Comparison fields: 5 of 113
- Pathology and Forensic Medicine 587
- Cancer Research 393
- Biomaterials 359
- Oncology 568
- Biomedical Engineering 844
Countries citing papers authored by Yu Chang
This map shows the geographic impact of Yu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Chang more than expected).
Fields of papers citing papers by Yu Chang
This network shows the impact of papers produced by Yu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Chang. The network helps show where Yu Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species Hit paper breakdown → | 2017 | 613 |
| 2 | 2018 | 296 | |
| 3 | 2018 | 157 | |
| 4 | 2016 | 107 | |
| 5 | 2013 | 84 | |
| 6 | 2017 | 83 | |
| 7 | 2017 | 76 | |
| 8 | 2018 | 72 | |
| 9 | 2017 | 67 | |
| 10 | 2016 | 47 | |
| 11 | 2014 | 44 | |
| 12 | 2017 | 44 | |
| 13 | 2018 | 39 | |
| 14 | 2018 | 38 | |
| 15 | 2024 | 34 | |
| 16 | 2019 | 34 | |
| 17 | Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways. | 2016 | 33 |
| 18 | 2018 | 32 | |
| 19 | 2013 | 32 | |
| 20 | Clinical analysis of pulmonary cryptococcosis in non-HIV patients in south China. | 2015 | 31 |
About Yu Chang
Yu Chang is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Cancer Research and Neurology, having authored 91 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), Viral-associated cancers and disorders (12 papers), Immune Cell Function and Interaction (9 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Cancer-related Molecular Pathways (6 papers), Nanoplatforms for cancer theranostics (6 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (587 citations), Cancer Research (393 citations), Biomaterials (359 citations), Oncology (568 citations) and Biomedical Engineering (844 citations). Yu Chang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ping’an Ma, JM Lin, Ziyong Cheng, Xinyang Zhang, Haihua Xiao, Zhaoming Li, Jianhua Liu, Chunxia Li, Zhen Nan Gu and Haiqin Song. Their work appears in journals such as Scientific Reports, Cancer Management and Research, Annals of Hematology, Oncology Reports and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.